Efficacy and safety of nivolumab plus chemotherapy in patients with advanced gastric cancer with massive ascites.

World J Gastrointest Oncol · 2026 · PMC12836160 · PMID 41607769

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, an analysis of other biomarkers showed a trend towards a higher prevalence of increased CLDN18.2 expression in the HAB group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.